Looking beyond blood glucose control: Preserving Kidney Function in T2DM
| Saturday, May 30, 2026 |
| 9:20 AM - 9:40 AM |
| Royal Benowa Ballroom |
Overview
Dr Carla Scuderi
Details
Type 2 diabetes remains one of the leading causes of chronic kidney disease in Australia, with many people experiencing progressive kidney damage long before symptoms appear. While glycaemic control remains important, growing evidence highlights the need to focus on preserving kidney function early in the course of disease.
This session will explore the mechanisms linking type 2 diabetes and progressive kidney dysfunction, including hyperfiltration, inflammation and albuminuria. It will also examine the role of pharmacotherapy in slowing kidney disease progression and supporting long-term renal outcomes. Through discussion of current evidence and treatment considerations, pharmacists will gain a clearer understanding of when and how medicines can be used to protect kidney function in people living with type 2 diabetes.
Learning Objectives:
• Describe the mechanisms linking type 2 diabetes with progressive kidney dysfunction.
• Discuss when pharmacotherapy may be recommended to help preserve kidney function in people living with type 2 diabetes.
Competency Standards (2016): 1.6, 3.1, 3.5, 3.6
Speaker
Dr Carla Scuderi
Assistant Director Of Pharmacy- Clinical
Royal Brisbane And Women's Hospital
Looking beyond blood glucose control: Preserving Kidney Function in T2DM
Biography
Dr Carla Scuderi is the Assistant Director of Pharmacy for clinical services at the Royal Brisbane and Women’s Hospital and is the co-chair of the Queensland Health Statewide Renal Clinical Network and is the chair of the AdPha Nephrology special interest group. A senior clinical pharmacist with 3 decades of experience in many facets of the pharmaceutical industry in both Australia and the UK. Roles include work for Queensland Health as clinical pharmacist, clinical educator and renal team leader, 5 years as an academic detailer for the National Prescribing Service, current Australian Pharmacy Council subject matter expert, Kidney Health Australia clinical advisory committee and she has also worked as a community pharmacist and Home Medicines Review pharmacist. Completing her PhD on the pharmacist’s role in kidney transplant care in 2024, Carla was awarded a Churchill fellowship in 2025.
